EDR Peptide (Pinealon) in Neuroprotection: Oxidative Stress Reduction and Anti-Apoptotic Mechanisms in Neural Tissue
Abstract
A structured review of the published Khavinson bioregulation literature on the tripeptide EDR (Pinealon), focusing on its reported neuroprotective mechanisms: reactive oxygen species suppression, caspase-3 modulation, and dendritic spine morphology restoration in preclinical models of hypoxia and neurodegeneration. RGC relevance is contextualized as a CNS-neuron neuroprotection target. Reference survey only; no clinical outcome is asserted.
Methods
- 01Scope : EDR neuroprotective mechanisms in neural tissue
- 02Sources : Khavinson group primary studies, cell models, animal models
- 03Extraction : ROS reduction, caspase-3 modulation, dendritic morphology
- 04Framing : neutral synthesis, no meta-analysis of human endpoints
DISCLOSURE : This report presents anonymized in-silico and/or observational reference data. It does not establish a causal relationship between any catalogued material and any physiological outcome, and it is not a claim of safety, efficacy, or benefit.
Relevant Reference Materials
This report's structural and literature findings are studied against the following catalogued reference material.